CompletedNot Applicable

Modified Adaptive Servoventilation (ASV) Compared to Conventional ASV

Germany21 participantsStarted 2011-07

Plain-language summary

This study will determine if modified adaptive servoventilation (ASV) is as effective as the conventional ASV in treating periodic breathing. The study will determine if the modified ASV reacts appropriately to reduce apneas and hypopneas and provides suitable levels of positive airway pressure compared to conventional ASV.

Who can participate

Age range21 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 21+ years old * Chronic ResMed ASV therapy patient * Current ASV therapy for at least 4 weeks * Able to understand fully the study information and participation requirements * Provide signed informed consent Exclusion Criteria: * Acute cardiac decompensation * Acute myocardial infarction within last 3 months * Resuscitation within last 3 months * Stroke with swallowing disorders or persistent hemiparesis * Blood pressure test at end expiratory pressure (EEP) 10cmH2O not passed * Untreated restless legs syndrome * Alcohol or drug abuse * Known cancer * Pregnancy * Conditions that could interfere with patients participating in and completing the protocol and/or the investigator deems their enrolment unsuitable

What they're measuring

Apnea/Hypopnea Index (AHI)

Timeframe: One night

Trial details

NCT IDNCT01405313

SponsorResMed

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2011-09

Results submitted2012-09-20

View on ClinicalTrials.gov More Periodic Breathing trials